Working… Menu
Trial record 58 of 326 for:    clonidine

Intra-articular Morphine and Clonidine Injections for Pain Management in Hip Arthroscopy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02530151
Recruitment Status : Completed
First Posted : August 20, 2015
Results First Posted : May 20, 2019
Last Update Posted : September 23, 2019
Information provided by (Responsible Party):
Michael Terry, Northwestern University

Brief Summary:
The purpose of this study is to determine whether intraoperative (during surgery) morphine and clonidine hip injections are effective in postoperative pain management for patients undergoing hip arthroscopy.

Condition or disease Intervention/treatment Phase
Femoracetabular Impingement Pain, Postoperative Drug: Morphine with clonidine Other: Normal saline Phase 4

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Prospective Assessment of Intraoperative Intra-articular Morphine and Clonidine Injection in Hip Arthroscopy on Postoperative Pain Management
Study Start Date : November 2015
Actual Primary Completion Date : May 2017
Actual Study Completion Date : May 2017

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Morphine with Clonidine
11 mL intra-articular injection of 10 mg morphine and 100 mcg clonidine in .9% NaCl solution at conclusion of hip arthroscopy procedure
Drug: Morphine with clonidine
see arm description

Placebo Comparator: Normal Saline
11 mL intra-articular injection of .9% NaCl solution at conclusion of hip arthroscopy procedure
Other: Normal saline
see arm description

Primary Outcome Measures :
  1. Opioid Consumption in the Acute Postoperative Period [ Time Frame: Recorded intraoperatively, during PACU stay, 6 hours post discharge, 18 hours post discharge, 24 hours post discharge, 48 hours post discharge, and at 7 days post discharge ]
    The total usage of opioid medication (mEq) for pain relief in the intraoperative period and again through the postoperative recovery period from arrival in the PACU through 7 days post op

Secondary Outcome Measures :
  1. Visual Analog Scale (VAS) Pain Scores [ Time Frame: Immediately preoperative (5-10 minutes before surgery), immediately postoperative (5-10 minutes after surgery), 1 hr post operatively ]
    Patients will rate their pain (0-10) on the Visual Analog Scale with higher scores for the VAS indicated elevated pain intensity reported by the patient for the indicated time point

  2. Quality of Recovery (QoR-15) Scores for Patient Reported Recovery Following Surgery [ Time Frame: Preoperative to 24 hrs. post operatively ]
    The Quality of Recovery questionnaire (QoR-15) is a 15 question patient reported outcome measure used to evaluate the quality of recovery following surgical anesthesia concerning pain, physical function, and psychological factors; reported as a summative score with each question graded between 0-10 (Range:0-150) with higher scores indicating improved physical/psychological recovery or infrequent symptoms

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Any patient undergoing a hip arthroscopy procedure for femoracetabular impingement by the senior surgeon (M.T.)

Exclusion Criteria:

  • Morphine contraindication
  • Clonidine contraindication
  • Pregnant women
  • Prisoners
  • Adults unable to consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02530151

Layout table for location information
United States, Illinois
Joshua Barett
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Layout table for investigator information
Principal Investigator: Michael Terry, MD Northwestern University
  Study Documents (Full-Text)

Documents provided by Michael Terry, Northwestern University:
Informed Consent Form  [PDF] October 30, 2015

Layout table for additonal information
Responsible Party: Michael Terry, Associate Professor in Orthopaedic Surgery, Northwestern University Identifier: NCT02530151     History of Changes
Other Study ID Numbers: STU00201218
First Posted: August 20, 2015    Key Record Dates
Results First Posted: May 20, 2019
Last Update Posted: September 23, 2019
Last Verified: September 2019
Keywords provided by Michael Terry, Northwestern University:
Hip arthroscopy
Intra-articular injection
Additional relevant MeSH terms:
Layout table for MeSH terms
Femoracetabular Impingement
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Neurologic Manifestations
Signs and Symptoms
Joint Diseases
Musculoskeletal Diseases
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Antihypertensive Agents
Autonomic Agents
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action